Hostility to GM putting EU in ‘global slow lane’

The growing influence of green lobbyists and anti-capitalists on European policymaking is condemning the EU the ‘global slow lane’ when it comes to biotechnology, a member of Britain’s Parliament has warned.

George Freeman, chairman of the All Party Group on Science and Technology in Agriculture, said ‘growing hostility’ to technologies like GM is already forcing some of the biggest biotechnology companies to abandon Europe as a market.

The UK and the rest of the EU are in danger of missing out on the ‘major opportunity’ presented by the revolution in the field of genomics to support farmers in boosting food production while also creating ‘huge new inward investment and export opportunities’, according to the Norfolk MP.

In a ‘Fresh Start Project’ report on the ‘EU Impact on Life Sciences’, Mr Freeman and think tank Open Europe’s Pawel Swidlicki call for a rethink in how biotech and other strands of Life Sciences are regulated bin the EU and say ‘serious consideration’ should given to repatriating this responsibility to the UK.

Read the full, original article: Hostility to GM putting EU in ‘global slow lane’ – report

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.